Krystal Biotech, Inc.
KRYS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711279
In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Krystal Biotech, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 160
- +8 vs. Q4 2022
- Shares held
- 21.0M
- +128.3K (+0.6%) vs. Q4 2022
- Total value
- $1.68B
- +$27.6M (+1.7%) vs. Q4 2022
- New holders
- 19
- 57 more added
- Sold out
- 11
- 55 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRYS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 422 | $11.1B |
| Q1 2026 | 368 | $7.32B |
| Q4 2025 | 334 | $7.01B |
| Q3 2025 | 284 | $4.94B |
| Q2 2025 | 275 | $3.80B |
| Q1 2025 | 299 | $4.98B |
| Q4 2024 | 264 | $4.35B |
| Q3 2024 | 283 | $5.15B |
| Q2 2024 | 245 | $5.24B |
| Q1 2024 | 234 | $4.49B |
| Q4 2023 | 194 | $3.03B |
| Q3 2023 | 188 | $2.76B |
| Q2 2023 | 183 | $2.71B |
| Q1 2023 | 160 | $1.68B |
| Q4 2022 | 154 | $1.66B |
| Q3 2022 | 148 | $1.45B |
| Q2 2022 | 137 | $1.36B |
| Q1 2022 | 135 | $1.37B |
| Q4 2021 | 140 | $1.35B |
| Q3 2021 | 113 | $850.7M |
| Q2 2021 | 113 | $1.12B |
| Q1 2021 | 113 | $1.27B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Krystal Biotech, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mutual of America Capital Management LLC | 25,551 | $2.05M | 0.02% | −1,177−4.4% | Reduced |
| Kennedy Capital Management, Inc. | 25,807 | $2.07M | 0.06% | −13−0.1% | Reduced |
| Alliancebernstein L.P. | 26,100 | $2.09M | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 26,119 | $2.09M | 0.00% | +17,927+218.8% | Added |
| UBS Group AG | 28,128 | $2.25M | 0.00% | −14,495−34.0% | Reduced |
| DekaBank Deutsche Girozentrale | 30,300 | $2.35M | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 29,893 | $2.39M | 0.00% | −6,455−17.8% | Reduced |
| State of New Jersey Common Pension Fund D | 29,901 | $2.39M | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 32,469 | $2.60M | 0.00% | +635+2.0% | Added |
| Voya Investment Management LLC | 33,154 | $2.65M | 0.00% | −29,455−47.0% | Reduced |
| Silverarc Capital Management, LLC | 34,014 | $2.72M | 1.22% | −24,521−41.9% | Reduced |
| CWM, LLC | 35,165 | $2.81M | 0.02% | −1,965−5.3% | Reduced |
| Swiss National Bank | 38,900 | $3.11M | 0.00% | −4,500−10.4% | Reduced |
| Balyasny Asset Management LLC | 41,135 | $3.29M | 0.01% | +32,759+391.1% | Added |
| Hennion & Walsh Asset Management, Inc. | 45,235 | $3.62M | 0.22% | +32+0.1% | Added |
| Norges Bank | 48,101 | $3.85M | 0.00% | +25,018+108.4% | Added |
| Citigroup Inc | 50,585 | $4.05M | 0.01% | +21,825+75.9% | Added |
| Invesco Ltd. | 51,580 | $4.13M | 0.00% | +23,537+83.9% | Added |
| Nuveen Asset Management, LLC | 52,931 | $4.24M | 0.00% | −4,481−7.8% | Reduced |
| Driehaus Capital Management LLC | 53,932 | $4.32M | 0.06% | +53,932 | New |
| International Biotechnology Trust PLC | 61,000 | $4.88M | 1.36% | +16,000+35.6% | Added |
| Rafferty Asset Management, LLC | 61,524 | $4.93M | 0.03% | −101−0.2% | Reduced |
| Bank of New York Mellon Corp | 79,563 | $6.37M | 0.00% | −2,533−3.1% | Reduced |
| Candriam Luxembourg S.C.A. | 92,000 | $6.78M | 0.05% | +92,000 | New |
| Integral Health Asset Management, LLC | 85,000 | $6.81M | 1.41% | −30,000−26.1% | Reduced |
| Soleus Capital Management, L.P. | 85,179 | $6.82M | 0.84% | −103,038−54.7% | Reduced |
| Bank of America Corp | 92,887 | $7.44M | 0.00% | +24,844+36.5% | Added |
| Verition Fund Management LLC | 93,644 | $7.50M | 0.12% | +13,083+16.2% | Added |
| Handelsbanken Fonder AB | 105,200 | $8.42M | 0.05% | 00.0% | Unchanged |
| Citadel Advisors LLC | 107,325 | $8.59M | 0.01% | +54,649+103.7% | Added |
| S Squared Technology, LLC | 108,215 | $8.66M | 5.14% | 00.0% | Unchanged |
| Morgan Stanley | 126,825 | $10.2M | 0.00% | +60,774+92.0% | Added |
| ExodusPoint Capital Management, LP | 136,141 | $10.9M | 0.12% | +30,380+28.7% | Added |
| Charles Schwab Investment Management Inc | 159,889 | $12.8M | 0.00% | −726−0.5% | Reduced |
| First Light Asset Management, LLC | 195,980 | $15.7M | 1.41% | −277,711−58.6% | Reduced |
| Northern Trust Corp | 201,477 | $16.1M | 0.00% | +189+0.1% | Added |
| Victory Capital Management Inc | 212,130 | $17.0M | 0.02% | −127,201−37.5% | Reduced |
| C WorldWide Group Holding A/S | 225,809 | $18.1M | 0.25% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 238,409 | $19.1M | 0.00% | +472+0.2% | Added |
| Goldman Sachs Group Inc | 257,860 | $20.6M | 0.01% | +110,259+74.7% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 286,018 | $22.9M | 0.16% | −1,523−0.5% | Reduced |
| Baker Bros. Advisors LP | 302,716 | $24.2M | 0.13% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 311,949 | $25.0M | 0.56% | +136,949+78.3% | Added |
| Braidwell LP | 348,036 | $27.9M | 0.92% | −10,020−2.8% | Reduced |
| Nicholas Investment Partners, LP | 374,718 | $30.0M | 2.28% | +107,629+40.3% | Added |
| Artal Group S.A. | 412,082 | $33.0M | 1.96% | +12,082+3.0% | Added |
| Geode Capital Management, LLC | 430,571 | $34.5M | 0.00% | +18,444+4.5% | Added |
| Hood River Capital Management LLC | 447,393 | $35.8M | 1.16% | +20,514+4.8% | Added |
| Dimensional Fund Advisors LP | 462,090 | $37.0M | 0.01% | +72,805+18.7% | Added |
| Point72 Asset Management, L.P. | 502,400 | $40.2M | 0.14% | −53,852−9.7% | Reduced |
| Pictet Asset Management SA | 632,393 | $50.6M | 0.06% | +6,414+1.0% | Added |
| Credit Suisse AG | 632,824 | $50.7M | 0.05% | −50,056−7.3% | Reduced |
| Frazier Life Sciences Management, L.P. | 945,407 | $75.7M | 5.48% | −54,330−5.4% | Reduced |
| Lord, Abbett & Co. LLC | 961,242 | $77.0M | 0.28% | −316,780−24.8% | Reduced |
| State Street Corp | 1,026,395 | $82.2M | 0.00% | −12,588−1.2% | Reduced |
| Vanguard Group Inc | 1,202,230 | $96.3M | 0.00% | +14,120+1.2% | Added |
| BlackRock Inc. | 1,716,095 | $137.4M | 0.00% | +16,499+1.0% | Added |
| Avoro Capital Advisors LLC | 1,750,000 | $140.1M | 2.08% | +340,000+24.1% | Added |
| Redmile Group, LLC | 1,913,280 | $153.2M | 6.65% | +16,635+0.9% | Added |
| FMR LLC | 2,196,958 | $175.9M | 0.02% | +88,105+4.2% | Added |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −92,609−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −21,698−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −21,605−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,224−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −15,123−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −10,354−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −5,694−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −5,133−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −5,096−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −2,629−100.0% | Sold out |
| Monarch Partners Asset Management LLC | – | – | – | – | Not filed |
| HealthInvest Partners AB | – | – | – | – | Not filed |